These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27995750)

  • 1. Keloid progression: a stiffness gap hypothesis.
    Huang C; Liu L; You Z; Wang B; Du Y; Ogawa R
    Int Wound J; 2017 Oct; 14(5):764-771. PubMed ID: 27995750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Interplay of Mechanical Stress, Strain, and Stiffness at the Keloid Periphery Correlates with Increased Caveolin-1/ROCK Signaling and Scar Progression.
    Dohi T; Padmanabhan J; Akaishi S; Than PA; Terashima M; Matsumoto NN; Ogawa R; Gurtner GC
    Plast Reconstr Surg; 2019 Jul; 144(1):58e-67e. PubMed ID: 31246819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis.
    Feng F; Liu M; Pan L; Wu J; Wang C; Yang L; Liu W; Xu W; Lei M
    Front Pharmacol; 2022; 13():906212. PubMed ID: 35614943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
    Ogawa R; Akaishi S
    Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of upper torso stress amplification, tissue compression and distortion in the pathogenesis of keloids.
    Bux S; Madaree A
    Med Hypotheses; 2012 Mar; 78(3):356-63. PubMed ID: 22230168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanobiology of scarring.
    Ogawa R
    Wound Repair Regen; 2011 Sep; 19 Suppl 1():s2-9. PubMed ID: 21793962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dissection of abnormal wound healing processes resulting in keloid disease.
    Shih B; Garside E; McGrouther DA; Bayat A
    Wound Repair Regen; 2010; 18(2):139-53. PubMed ID: 20002895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In the face and neck, keloid scar distribution is related to skin thickness and stiffness changes associated with movement.
    Cho H; Dohi T; Wakai H; Quong WL; Linh NDT; Usami S; Ogawa R
    Wound Repair Regen; 2024; 32(4):419-428. PubMed ID: 38602106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The keloid phenomenon: progress toward a solution.
    Louw L
    Clin Anat; 2007 Jan; 20(1):3-14. PubMed ID: 16944532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between keloid growth pattern and stretching tension: visual analysis using the finite element method.
    Akaishi S; Akimoto M; Ogawa R; Hyakusoku H
    Ann Plast Surg; 2008 Apr; 60(4):445-51. PubMed ID: 18362577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling aberrant wound healing using tissue-engineered skin constructs and multiphoton microscopy.
    Torkian BA; Yeh AT; Engel R; Sun CH; Tromberg BJ; Wong BJ
    Arch Facial Plast Surg; 2004; 6(3):180-7. PubMed ID: 15148128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of keloids through Runx2 siRNA‑induced inhibition of the PI3K/AKT signaling pathway.
    Lv W; Wu M; Ren Y; Luo X; Hu W; Zhang Q; Wu Y
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keloids--clinical diagnosis, pathogenesis, and treatment options.
    Marneros AG; Krieg T
    J Dtsch Dermatol Ges; 2004 Nov; 2(11):905-13. PubMed ID: 16281608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
    Dienus K; Bayat A; Gilmore BF; Seifert O
    Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.
    Chipev CC; Simon M
    BMC Dermatol; 2002 Nov; 2():13. PubMed ID: 12445328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.
    Andrews JP; Marttala J; Macarak E; Rosenbloom J; Uitto J
    Matrix Biol; 2016 Apr; 51():37-46. PubMed ID: 26844756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia upregulates VEGF production in keloid fibroblasts.
    Steinbrech DS; Mehrara BJ; Chau D; Rowe NM; Chin G; Lee T; Saadeh PB; Gittes GK; Longaker MT
    Ann Plast Surg; 1999 May; 42(5):514-9; discussion 519-20. PubMed ID: 10340860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The mast cell and trauma].
    Deng WN; Wang CY; Liu L
    Fa Yi Xue Za Zhi; 2002 May; 18(2):121-3. PubMed ID: 12596601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway.
    Park G; Yoon BS; Moon JH; Kim B; Jun EK; Oh S; Kim H; Song HJ; Noh JY; Oh C; You S
    J Invest Dermatol; 2008 Oct; 128(10):2429-41. PubMed ID: 18463684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.